Search research articles
Contact Us
Filters
Showing results (81-90 of 434) with videos related to
Page
of 44
Sort By:
Journal of Forensic Sciences
|
November 21, 2017
Authors' Response
John A Gibbons, Alan Ashworth, Andrew J Mojica, et al.
DNA Repair
|
April 11, 2013
Identification of miRNA modulators to PARP inhibitor response
Sari Neijenhuis, Ilirjana Bajrami, Rowan Miller, et al.
ACS Medicinal Chemistry Letters
|
May 14, 2025
Discovery of a Novel [6-6-5-5-6] Pentacyclic Tetrahydrocyclopentaphthalazinone as a Promising PARP Inhibitor Scaffold
Yagmur U Doruk, Morgan E Diolaiti, Alan Ashworth, et al.
Nature Communications
|
April 13, 2019
A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers
Gourish Mondal, Meredith Stevers, Benjamin Goode, et al.
Preventive Oncology & Epidemiology
|
March 25, 2024
Cancer Research in 2030: A unique strategic planning process at a comprehensive cancer center
Erin M Bank, Eric J Small, Alan Ashworth, et al.
Oncogene
|
July 25, 2003
Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1
James Spicer, Sydonia Rayter, Neville Young, et al.
The Journal of Investigative Dermatology
|
October 26, 2007
Dynamic expression of Erbb pathway members during early mammary gland morphogenesis
Olivia Wansbury, Heena Panchal, Michelle James, et al.
BMC Genomics
|
July 12, 2011
An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence
Emilie Rovillain, Louise Mansfield, Christopher J Lord, et al.
Human Molecular Genetics
|
April 4, 2002
Structural analysis of the chicken BRCA2 gene facilitates identification of functional domains and disease causing mutations
Madhuri Warren, Amanda Smith, Natalie Partridge, et al.
Cancer Research
|
January 19, 2011
Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers
Sarah A Martin, Madeleine Hewish, David Sims, et al.
Page
of 44
Search research articles
Search
Showing results (81-90 of 434) with videos related to
Sort By:
Page
of 44
Journal of Forensic Sciences
|
November 21, 2017
Authors' Response
John A Gibbons, Alan Ashworth, Andrew J Mojica, et al.
DNA Repair
|
April 11, 2013
Identification of miRNA modulators to PARP inhibitor response
Sari Neijenhuis, Ilirjana Bajrami, Rowan Miller, et al.
ACS Medicinal Chemistry Letters
|
May 14, 2025
Discovery of a Novel [6-6-5-5-6] Pentacyclic Tetrahydrocyclopentaphthalazinone as a Promising PARP Inhibitor Scaffold
Yagmur U Doruk, Morgan E Diolaiti, Alan Ashworth, et al.
Nature Communications
|
April 13, 2019
A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers
Gourish Mondal, Meredith Stevers, Benjamin Goode, et al.
Preventive Oncology & Epidemiology
|
March 25, 2024
Cancer Research in 2030: A unique strategic planning process at a comprehensive cancer center
Erin M Bank, Eric J Small, Alan Ashworth, et al.
Oncogene
|
July 25, 2003
Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1
James Spicer, Sydonia Rayter, Neville Young, et al.
The Journal of Investigative Dermatology
|
October 26, 2007
Dynamic expression of Erbb pathway members during early mammary gland morphogenesis
Olivia Wansbury, Heena Panchal, Michelle James, et al.
BMC Genomics
|
July 12, 2011
An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence
Emilie Rovillain, Louise Mansfield, Christopher J Lord, et al.
Human Molecular Genetics
|
April 4, 2002
Structural analysis of the chicken BRCA2 gene facilitates identification of functional domains and disease causing mutations
Madhuri Warren, Amanda Smith, Natalie Partridge, et al.
Cancer Research
|
January 19, 2011
Parallel high-throughput RNA interference screens identify PINK1 as a potential therapeutic target for the treatment of DNA mismatch repair-deficient cancers
Sarah A Martin, Madeleine Hewish, David Sims, et al.
Page
of 44